
脂肪原/地高辛/CDX-D0175-G005/5 g
商品编号:
CDX-D0175-G005
品牌:
Adipogen Inc
市场价:
¥8480.00
美元价:
5088.00
产品分类:
其他试剂
公司分类:
Other_reagents
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
ProductDetails | |
---|---|
Synonyms | 12β-Hydroxydigitoxin;NSC95100 |
ProductType | Chemical |
Properties | |
Formula | C41H64O14 |
MW | 780.94 |
CAS | 20830-75-5 |
Source/HostChemicals | Synthetic. |
PurityChemicals | ≥95%(HPLC) |
Appearance | Whitepowder. |
Solubility | SolubleinDMSO(100mM)ormethanol. |
Identity | DeterminedbyNMR. |
Declaration | ManufacturedbyChemodex. |
OtherProductData | ClickhereforOriginalManufacturerProductDatasheet Ourproductdescriptionmaydifferslightlyfromtheoriginalmanufacturersproductdatasheet. |
InChiKey | LTMHDMANZUZIPE-PUGKRICDSA-N |
ShippingandHandling | |
Shipping | AMBIENT |
ShortTermStorage | +4°C |
LongTermStorage | -20°C |
HandlingAdvice | Keepcoolanddry. Protectfromlightandmoisture. |
Use/StABIlity | Stableforatleast2yearsafterreceiptwhenstoredat-20°C. |
Documents | |
MSDS | No |
ProductSpecificationSheet | |
Datasheet | ![]() |
CardiacglycosidefromtheleavesofDigitalislanata.Itisusedtotreatcardiacarrhythmias.ItisoftenusedasamodelsubstrateofP-glycoprotein(Pgp)(0.01-10µM)andaninhibitorofNa+/K+-ATPase.Inhibitsmembrane-boundα-subunitsoftheNa+/K+ATPasepumpinmyocytes.TheprimarymechanismofactioninvolvesinhibitionoftheNa+/K+ATPase,mainlyinthemyocardium.Thisinhibitioncausesanincreaseinintracellularsodiumlevels,resultinginareversaloftheactionofthesodium-calciumexchanger,whichcausesanincreaseintheintracellularcalciumconcentration.Thisleadstoadecreaseinheartrateandincreasedstorageofcalciuminthesarcoplasmicreticulum,causingacorrespondingincreaseinthereleaseofcalciumduringeachactionpotential.
ProductReferences
(1)R.G.Woolfson,etal.;KidneyInt.46,297(1994)|(2)S.Reddy,etal.;Curr.Opin.Cardiol.12,233(1997)|(3)K.Kjeldsen&H.Bundgaard;Ann.NYAcad.Sci.986,702(2003)|(4)M.Gheorghiade,etal.;Circulation109,2959(2004)|(5)M.Ehle,etal.;Crit.Pathw.Cardiol.10,93(2011)|(6)R.J.Biggar;Clin.CancerRes.18,2133(2012)|(7)A.M.Nader&D.R.Foster;J.Clin.Pharmacol.54,3(2014)|(8)G.A.Ewy;Am.J.Med.128,1272(2015)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。
联络我们